Effect of Thymostimulin on Human Lymphocyte Adenosine Deaminase and Purine Nucleoside Phosphorylase Activities: Physiological and Therapeutic Effects

  • F. Ambrogi
  • M. Petrini
  • F. Caracciolo
  • A. Azzara
  • G. Carulli
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 166)

Abstract

Thymostimulin (TP1 — Serono), which has several immunobiological activities in vivo and in vitro, is a pool of thermostable polypeptides extracted from calf thymus and has been used in the treatment of primary and secondary immunodeficiencies (1, 2). However, the immunobiological properties and the mechanism of action of this cellular extract is still not completely understood. For this reason, we have studied the activity of thymostimulin on the intracellular levels of adenosine deaminase (ADA) and purine nucleoside phosphorylase (PNP) enzymes in peripheral blood lymphocytes of patients with hematological malignancies. We also hoped to reveal the effects of thymostimulin on lymphocytes from cord blood and from elderly patients. In fact, these enzymes have important roles in both lymphocyte ontogenesis (3, 4) and in the maintenance of immunological functions (5, 6).

Keywords

Chronic Lymphocytic Leukaemia Cord Blood Adenosine Deaminase Purine Nucleoside Phosphory Adenosine Deaminase Activity 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Fiorilli, M., R. Ammirati, M. C. Sirianni, R. D’Amelio, I. Quinti, M. C. Voci, and F. Aiuti. 1980. In Thymus, thymic hormones and T lymphocytes. F. Aiuti and H. Wigzell (eds.), Academic Press, London.Google Scholar
  2. 2.
    Falchetti, R., G. Bergesi, A. Esvol, C. Cafiero, L. Adorini, and L. Caprino. 1977. Drugs Exp. Clin. Res. 3: 39.Google Scholar
  3. 3.
    Barton, R., F. Martiniuk, P. Hirschnorn, and I. Goldschneider. 1980. Cell. Immunol. 49: 208.PubMedCrossRefGoogle Scholar
  4. 4.
    Petrini, M., R. Testi, N. Capelli, F. Caracciolo, S. Ronca-Testoni, and F. Ambrogi. 1980. In F. Gasosto, G. P. Bagnara, M. A. Brunelli, and C. Castaldini (eds.), Editrice Esculapio, Bologna.Google Scholar
  5. 5.
    Giblett, E., E. Anderson, E. Cohen, B. Pollara, and H. J. Meuwissen. 1972. Lancet 2: 1067.PubMedCrossRefGoogle Scholar
  6. 6.
    Giblett, E., A. T. Amman, D. W. Wara, R. Sandman, and L. K. Diamon. 1975. Lancet 1: 1010.PubMedCrossRefGoogle Scholar
  7. 7.
    Ambrogi, F., B. Grassi, S. Ronca-Testoni, and G. Ronca. 1977. Clin. Exp. Immunol. 28: 80.Google Scholar
  8. 8.
    Petrini, M., A. Azzara, R. Polidori, Maria L. Vatteroni, F. Càracciolo, G. Carulli, and F. Ambrogi. 1982. Clin. Immunol. Immunopathol. 23: 124PubMedCrossRefGoogle Scholar
  9. 9.
    Ambrogi, F. 1982. Cell. Immunol. (in press).Google Scholar
  10. 10.
    Petrini, M., R. Polidori, A. Azzara, Maria L. Vatteroni, and F. Ambrogi. 1981. Curr. Therap. Res. 30: 367.Google Scholar

Copyright information

© Springer Science+Business Media New York 1983

Authors and Affiliations

  • F. Ambrogi
    • 1
  • M. Petrini
    • 1
  • F. Caracciolo
    • 1
  • A. Azzara
    • 1
  • G. Carulli
    • 1
  1. 1.I Clinica MedicaUniversità di Pisa, Ospedali S. ChiaraPisaItaly

Personalised recommendations